Pernix Therapeutics Holdings Inc. (fka PTXTQ)

[awaitingamove]

Morgan Stanley Boosts Position in Pernix Therapeutics Holdings Inc (PTX)
Posted by Shane Hupp on May 4th, 2016 // No Comments

Pernix Therapeutics Holdings logoMorgan Stanley raised its stake in shares of Pernix Therapeutics Holdings Inc (NYSE:PTX) by 48,456.0% during the fourth quarter, Holdings Channel reports. The fund owned 5,160,043 shares of the specialty pharmaceutical company’s stock after buying an additional 5,149,416 shares during the period. Morgan Stanley owned about 8.45% of Pernix Therapeutics Holdings worth $15,222,000 at the end of the most recent quarter.
Pernix Therapeutics Holdings Inc (NYSE:PTX) traded down 3.64% during trading on Wednesday, reaching $1.06. 7,532,120 shares of the company’s stock were exchanged. Pernix Therapeutics Holdings Inc has a 12 month low of $0.73 and a 12 month high of $7.10. The firm has a 50 day moving average of $0.98 and a 200-day moving average of $2.17. The stock’s market cap is $64.72 million.
Pernix Therapeutics Holdings (NYSE:PTX) last posted its quarterly earnings results on Thursday, March 10th. The specialty pharmaceutical company reported ($0.59) EPS for the quarter, missing the consensus estimate of $0.01 by $0.60. On average, equities research analysts anticipate that Pernix Therapeutics Holdings Inc will post $0.09 earnings per share for the current fiscal year.